Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #10855 on CryoPort Inc (CYRX)
H2R
11/02/17 4:38 PM
#10856 RE: ConstitutionNow #10855
We are now supporting a record-breaking 195 clinical trials, with 23 new clinical trials secured in the third quarter, driving a 65% year-over-year revenue increase in our lead market, the biopharma market. We are proud of the significant traction we have made in supporting our client's clinical trials. We believe that this activity is the just the 'tip of the iceberg' as our biopharma market revenue is expected to significantly ramp as our clients' regenerative therapies reach commercial viability, requiring more extensive logistics support from Cryoport.